Phase I dose-escalation study of the SRC and multi-kinase inhibitor BMS-354825 in patients (pts) with GIST and other solid tumors

Abstract only

Saved in:
Bibliographic Details
Published in:Journal of clinical oncology Vol. 23; no. 16_suppl; p. 3034
Main Authors: Evans, T. R. J., Morgan, J. A., van den Abbeele, A. D., McPherson, I. R. J., George, S., Crawford, D., Mastrullo, J. M., Cheng, S., Fletcher, J. A., Demetri, G. D.
Format: Journal Article
Language:English
Published: 01-06-2005
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Abstract only
AbstractList Abstract only
Author Evans, T. R. J.
George, S.
Mastrullo, J. M.
Cheng, S.
Morgan, J. A.
van den Abbeele, A. D.
McPherson, I. R. J.
Fletcher, J. A.
Crawford, D.
Demetri, G. D.
Author_xml – sequence: 1
  givenname: T. R. J.
  surname: Evans
  fullname: Evans, T. R. J.
  organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT
– sequence: 2
  givenname: J. A.
  surname: Morgan
  fullname: Morgan, J. A.
  organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT
– sequence: 3
  givenname: A. D.
  surname: van den Abbeele
  fullname: van den Abbeele, A. D.
  organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT
– sequence: 4
  givenname: I. R. J.
  surname: McPherson
  fullname: McPherson, I. R. J.
  organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT
– sequence: 5
  givenname: S.
  surname: George
  fullname: George, S.
  organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT
– sequence: 6
  givenname: D.
  surname: Crawford
  fullname: Crawford, D.
  organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT
– sequence: 7
  givenname: J. M.
  surname: Mastrullo
  fullname: Mastrullo, J. M.
  organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT
– sequence: 8
  givenname: S.
  surname: Cheng
  fullname: Cheng, S.
  organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT
– sequence: 9
  givenname: J. A.
  surname: Fletcher
  fullname: Fletcher, J. A.
  organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT
– sequence: 10
  givenname: G. D.
  surname: Demetri
  fullname: Demetri, G. D.
  organization: Beatson Oncology Ctr, Univ of Glasgow, Glasgow, United Kingdom; Dana-Faber Cancer Institute Harvard Med Sch, Boston, MA; Bristol-Myers Squibb, Wallingford, CT
BookMark eNo10M1LwzAYx_EgE9ym_0O86SE1L02THnXoHEwUN8FbSNOUZXZNaVJkR_9zW19OP3jg-R4-MzBpfGMBuCQ4IRTjm73xybA8oSwhmQp929YJwyw9AVPCqUBCcD4BUywYRUSy9zMwC2GPMUkl41Pw9bLTwcIVLH2wyAajax2db2CIfXmEvoJxZ-HmdQF1U8JDX0eHPlwz_rhm5woXfQfvnjaI8VRSPhxhOwRsEwO8amO4hp8u7uBytdn-FPyQ62DwtSth7A--C-fgtNJ1sBd_OwdvD_fbxSNaPy9Xi9s1MgRnKcoZyYnOS20YN6bgTBvMZW4otxRnpZWiMBJzahjBWMpUiLwqssxoQdMy14zNQf7bNZ0PobOVajt30N1REaxGSzVYqtFSUab-LdVoyb4BE69sFA
CitedBy_id crossref_primary_10_1517_14728222_10_6_793
crossref_primary_10_1158_1078_0432_CCR_08_0533
crossref_primary_10_1093_annonc_mdm223
crossref_primary_10_1093_annonc_mdn048
crossref_primary_10_1158_1535_7163_MCT_06_0382
crossref_primary_10_1158_1078_0432_CCR_09_2416
crossref_primary_10_1097_CCO_0b013e3281338885
crossref_primary_10_1007_s10637_012_9805_y
crossref_primary_10_1007_s11912_008_0053_4
crossref_primary_10_1038_nrclinonc_2009_129
crossref_primary_10_1016_j_ddstr_2005_11_005
crossref_primary_10_1056_NEJMoa055229
crossref_primary_10_1158_1078_0432_CCR_09_0190
crossref_primary_10_1002_pbc_21368
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1200/jco.2005.23.16_suppl.3034
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1527-7755
EndPage 3034
ExternalDocumentID 10_1200_jco_2005_23_16_suppl_3034
GroupedDBID ---
.55
.GJ
08G
08P
0R~
18M
29K
2WC
34G
39C
3O-
4.4
53G
5GY
5RE
5VS
8F7
8WZ
A6W
AAKAS
AAQOH
AAQQT
AARDX
AAWTL
AAYEP
AAYOK
AAYXX
ABJNI
ABOCM
ACGFO
ACGFS
ACGUR
ADBBV
ADZCM
AEGXH
AENEX
AFFNX
AI.
AIAGR
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AWKKM
AZFZN
BAWUL
C45
CITATION
CS3
D-I
DIK
EBS
EJD
EX3
F5P
F9R
FBNNL
FD8
FEDTE
GX1
H13
HVGLF
HZ~
IH2
IPNFZ
J5H
K-O
KQ8
L7B
LSO
MJL
N4W
N9A
NTWIH
O9-
OK1
OVD
OWW
P2P
QTD
R1G
RHI
RIG
RLZ
RUC
SJN
SV3
TEORI
TR2
TWZ
UDS
UHU
VH1
VVN
WH7
WOQ
WOW
X7M
YCJ
YFH
YQY
ZGI
ID FETCH-LOGICAL-c1064-93191a9dac35ccb53ac0589c25e206de87bc8052c3100884779fb66ca724d9a33
ISSN 0732-183X
IngestDate Fri Aug 23 01:44:43 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 16_suppl
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1064-93191a9dac35ccb53ac0589c25e206de87bc8052c3100884779fb66ca724d9a33
PageCount 1
ParticipantIDs crossref_primary_10_1200_jco_2005_23_16_suppl_3034
PublicationCentury 2000
PublicationDate 2005-06-00
PublicationDateYYYYMMDD 2005-06-01
PublicationDate_xml – month: 06
  year: 2005
  text: 2005-06-00
PublicationDecade 2000
PublicationTitle Journal of clinical oncology
PublicationYear 2005
SSID ssj0014835
Score 1.8181343
Snippet Abstract only
SourceID crossref
SourceType Aggregation Database
StartPage 3034
Title Phase I dose-escalation study of the SRC and multi-kinase inhibitor BMS-354825 in patients (pts) with GIST and other solid tumors
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9RAEF-uFYovolXxmxGkKNuN101ySR5Pe9pTKkcvQt9CdrPhTjEpTe-hj_7nzu5mk9gifoAv4W5ghyTzy8zs7HwQ8iIXZThWec5iWQgWhKViSRKWLEDzIsaRFEmsa4ePltGn0_hwFsxGIzeBtKf9V0kjDWWtK2f_QtodUyTgb5Q5XlHqeP0juS9WaJfonBZ1o5hqUARWxI3rHq09zeWJzdk06YTs67rSa9bVai3wAz-nb46XzMdNBg9p33rVhGfPdNZFYqO37-fL1HAxRVwUH2td0IvNt7o9ILru8nZlmHUlfwrnd_586tETj37wOhyYqVMGah6ddmRddIUKk06FUMomRE89etgvk4uV2UoYFTjk6QIcYZ-I1erByOcMNc-pNVmtnuYRbgxsh1-nyG3hsgPsJGv0XNSBckZrHQwMvft7zYhwMx_7i6xtyI37nmPm9SyGjbuvGNQuzVFvsJBFhqz0uM8w437mWGWa1Ra5wVFBmlDA_GN3-hXEdjCse_Ad8ry9r9e_vKuBXzVwkNLb5FYrZphaSN4hI1Xtkp3jNndjl-wtbJf0y31I-6K_Zh_2YNH3T7-8S74bCMMcrkAYDIShLgHxBghhQPDBEMLQQRh6CCMRHIThJQL4FWj4goav4WDgCwa-YOF7j3x-N0vfHrF2UgiTB-hTswQNyUGeFLn0QylF6OdSj8uUPFR8PClUHAmpZ3dIfZwVo0MWJaWYTGQe8aBIct-_T7arulIPCAj0-HG1H0VlHpR-mOTxWJbIPZalkkXxkHD3nrMz2xAm-62cH_3LosfkZv85PCHbF-cb9ZRsNcXmmYHLD1bmrVg
link.rule.ids 315,782,786,27933,27934
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Phase+I+dose-escalation+study+of+the+SRC+and+multi-kinase+inhibitor+BMS-354825+in+patients+%28pts%29+with+GIST+and+other+solid+tumors&rft.jtitle=Journal+of+clinical+oncology&rft.au=Evans%2C+T.+R.+J.&rft.au=Morgan%2C+J.+A.&rft.au=van+den+Abbeele%2C+A.+D.&rft.au=McPherson%2C+I.+R.+J.&rft.date=2005-06-01&rft.issn=0732-183X&rft.eissn=1527-7755&rft.volume=23&rft.issue=16_suppl&rft.spage=3034&rft.epage=3034&rft_id=info:doi/10.1200%2Fjco.2005.23.16_suppl.3034&rft.externalDBID=n%2Fa&rft.externalDocID=10_1200_jco_2005_23_16_suppl_3034
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0732-183X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0732-183X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0732-183X&client=summon